Treatment with the novel TAAR1 agonist ulotaront is associated with reductions in quantitative polysomnographic REM sleep without atonia in healthy human subjects: Results of a post-hoc analysis
Title:
Treatment with the novel TAAR1 agonist ulotaront is associated with reductions in quantitative polysomnographic REM sleep without atonia in healthy human subjects: Results of a post-hoc analysis
Author:
Feemster, John C. Westerland, Sarah M. Gossard, Thomas R. Steele, Tyler A. Timm, Paul C. Jagielski, Jack T. Strainis, Emma McCarter, Stuart J. Hopkins, Seth C. Koblan, Kenneth S. St. Louis, Erik K.